모르포린
MORPHOLINE
Nombres y definiciones oficiales
JCIA 표시명 モルホリン: 本品は、次の化学式で表される複素環式化合物である。
Nombres e identificadores
MORPHOLINEINCI모르포린식약처 표준명Morpholine식약처 표준명MORPHOLINE동의어
- cas
- 110-91-8
- ec
- 203-815-1
- dtxsid
- DTXSID2025688
- dtxcid
- DTXCID305688
- IUPAC
- Morpholine
- 분자식
- C4H9NO
- 분자량
- 87.122 g/mol
Funciones cosméticas
BUFFERING
Referencias de seguridad y regulación
Restriction II/344
MFDS(식약처) 국가별 사용 제한/금지 기록
식약처 규제 요약: 금지 국가 EU,브라질,아르헨티나,아세안,중국,캐나다,한국 / 제한 국가 없음
식약처 국가별 규제 정보: 아르헨티나 · 금지
식약처 국가별 규제 정보: 브라질 · 금지
식약처 국가별 규제 정보: 아세안 · 금지
식약처 국가별 규제 정보: 캐나다 · 금지
식약처 국가별 규제 정보: 중국 · 금지
식약처 국가별 규제 정보: 한국 · 금지
식약처 국가별 규제 정보: EU · 금지
출처:
Registros oficiales vinculados
- Japan Cosmetic Industry Association labelling names · jcia_label_name · Morpholine
- Japan Cosmetic Industry Association labelling names · jcia_label_name · Morpholine
- MFDS cosmetics regulatory ingredient information · regulation_summary · 모르포린
- MFDS cosmetics regulatory ingredient information · restricted_ingredient · 모르포린
- MFDS cosmetics regulatory ingredient information · restricted_ingredient · 모르포린
- MFDS cosmetics regulatory ingredient information · restricted_ingredient · 모르포린
- MFDS cosmetics regulatory ingredient information · restricted_ingredient · 모르포린
Literatura relacionada
- Network-based exploration of 4-(phenylsulfonyl)morpholine molecules for metastatic triple-negative breast cancer suppression · 2026
- Exploring Antiproliferative Potential, In Silico Docking, and Molecular Dynamics of Pyrimidine-Morpholine Hybrid Molecules · 2025
- Synthesis of 4‐Azaindole‐morpholine‐1,3,4‐oxadiazole Conjugates as Epidermal Growth Factor Receptor Inhibitors · 2022
- Study of mutagenic effects with predicted carcinogenicity of 4-((5-decylthio)-4-methyl-4-H-1,2,4-triazole-3-yl)methyl)morpholine for further research in order to create a new drug with antifungal activity · 2022
- INFLUENCE OF MORPHOLINE ON CHANGES IN KIDNEY TISSUE AND WHITE BLOOD CELLS OF NMRI MALE ALBINO MICE · 2014